Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Changes in tryptophan and kynurenine pathway metabolites in the blood of children treated with ketogenic diet for refractory epilepsy.

Żarnowska I, Wróbel-Dudzińska D, Tulidowicz-Bielak M, Kocki T, Mitosek-Szewczyk K, Gasior M, Turski WA.

Seizure. 2019 Jul;69:265-272. doi: 10.1016/j.seizure.2019.05.006. Epub 2019 May 9.

PMID:
31129366
2.

[Development in the first year of life of newborns born prematurely - preliminary report].

Zdzienicka-Chyła AM, Mitosek-Szewczyk K.

Dev Period Med. 2018;22(3):247-254. Polish.

PMID:
30281520
3.

Therapeutic use of carbohydrate-restricted diets in an autistic child; a case report of clinical and 18FDG PET findings.

Żarnowska I, Chrapko B, Gwizda G, Nocuń A, Mitosek-Szewczyk K, Gasior M.

Metab Brain Dis. 2018 Aug;33(4):1187-1192. doi: 10.1007/s11011-018-0219-1. Epub 2018 Apr 11.

4.

Kynurenic Acid and Neuroprotective Activity of the Ketogenic Diet in the Eye.

Zarnowski T, Tulidowicz-Bielak M, Zarnowska I, Mitosek-Szewczyk K, Wnorowski A, Jozwiak K, Gasior M, Turski WA.

Curr Med Chem. 2017;24(32):3547-3558. doi: 10.2174/0929867324666170509120257. Review.

PMID:
28486923
5.

[Headaches in autoimmune diseases].

Buczek E, Mitosek-Szewczyk K, Szajnoga B, Wierzchowska-Cioch E, Szewczyk A.

Wiad Lek. 2016;69(6):773-777. Review. Polish.

PMID:
28214814
6.
7.

Symptomatology and pathogenesis of different types of pain in multiple sclerosis.

Brola W, Mitosek-Szewczyk K, Opara J.

Neurol Neurochir Pol. 2014;48(4):272-9. doi: 10.1016/j.pjnns.2014.07.009. Epub 2014 Jul 30. Review.

PMID:
25168327
8.

Quality of life in Polish patients with multiple sclerosis.

Mitosek-Szewczyk K, Kułakowska A, Bartosik-Psujek H, Hożejowski R, Drozdowski W, Stelmasiak Z.

Adv Med Sci. 2014 Mar;59(1):34-8. doi: 10.1016/j.advms.2013.07.002. Epub 2014 Mar 16.

PMID:
24797971
9.

[Headaches and multiple sclerosis].

Buczek E, Mitosek-Szewczyk K, Szajnoga B, Wierzchowska-Cioch E.

Wiad Lek. 2014;67(2 Pt 1):97-100. Review. Polish.

PMID:
25764784
10.

Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis.

Mitosek-Szewczyk K, Tabarkiewicz J, Wilczynska B, Lobejko K, Berbecki J, Nastaj M, Dworzanska E, Kolodziejczyk B, Stelmasiak Z, Rolinski J.

J Neurol Sci. 2013 Sep 15;332(1-2):35-40. doi: 10.1016/j.jns.2013.06.003. Epub 2013 Jul 6.

PMID:
23835090
11.

Some markers of neuronal damage in cerebrospinal fluid of multiple sclerosis patients in relapse.

Mitosek-Szewczyk K, Gordon-Krajcer W, Flis D, Stelmasiak Z.

Folia Neuropathol. 2011;49(3):191-6.

12.

[Processes of free radical lipid peroxidation with a particular regard to the role of paraoxonase-1 in the pathogenesis of multiple sclerosis].

Berbecki J, Mitosek-Szewczyk K, Kurzepa J, Nastaj M, Łobejko K, Stelmasiak Z.

Wiad Lek. 2011;64(1):31-6. Review. Polish.

PMID:
21812361
13.

Selected aspects of the epidemiology of multiple sclerosis in Poland - a multicentre pilot study.

Kułakowska A, Bartosik-Psujek H, Hożejowski R, Mitosek-Szewczyk K, Drozdowski W, Stelmasiak Z.

Neurol Neurochir Pol. 2010 Sep-Oct;44(5):443-52.

PMID:
21082490
14.

Free radical peroxidation products in cerebrospinal fluid and serum of patients with multiple sclerosis after glucocorticoid therapy.

Mitosek-Szewczyk K, Gordon-Krajcer W, Walendzik P, Stelmasiak Z.

Folia Neuropathol. 2010;48(2):116-22.

15.

Impact of cladribine on soluble adhesion molecules in multiple sclerosis.

Mitosek-Szewczyk K, Stelmasiak Z, Bartosik-Psujek H, Belniak E.

Acta Neurol Scand. 2010 Dec;122(6):409-13. doi: 10.1111/j.1600-0404.2010.01330.x.

PMID:
20175758
16.

B-type natriuretic peptide as a marker of subclinical heart injury during mitoxantrone therapy in MS patients--preliminary study.

Luchowski P, Mitosek-Szewczyk K, Bartosik-Psujek H, Rubaj A, Jankiewicz M, Wojczal J, Szczepańska-Szerej A, Stelmasiak Z.

Clin Neurol Neurosurg. 2009 Oct;111(8):676-8. doi: 10.1016/j.clineuro.2009.06.007. Epub 2009 Jul 25.

PMID:
19632767
17.

[Fatigue in multiple sclerosis].

Dworzańska E, Mitosek-Szewczyk K, Stelmasiak Z.

Neurol Neurochir Pol. 2009 Jan-Feb;43(1):71-6. Review. Polish.

PMID:
19353446
18.

Expression of glutamate transporters GLT-1 and GLAST in different regions of rat brain during the course of experimental autoimmune encephalomyelitis.

Mitosek-Szewczyk K, Sulkowski G, Stelmasiak Z, Struzyńska L.

Neuroscience. 2008 Jul 31;155(1):45-52. doi: 10.1016/j.neuroscience.2008.05.025. Epub 2008 May 24.

PMID:
18572325
19.

[Validation of selected aspects of psychometry of the Polish version of the Multiple Sclerosis Impact Scale 29 (MSIS-29)].

Jamroz-Wiśniewska A, Papuć E, Bartosik-Psujek H, Belniak E, Mitosek-Szewczyk K, Stelmasiak Z.

Neurol Neurochir Pol. 2007 May-Jun;41(3):215-22. Polish.

PMID:
17629814
20.

Generalized botulism: diagnostic problems in a patient treated with botulinum toxin type A.

Fota-Markowska H, Mitosek-Szewczyk K, Hasiec T.

Acta Ophthalmol Scand. 2007 Mar;85(2):231-2. No abstract available.

21.

Unilateral progressive brain lesions confirmed as multiple sclerosis.

Mitosek-Szewczyk K, Luchowski P, Jarosz B, Stelmasiak Z.

Eur J Neurol. 2007 Jan;14(1):e34-5. No abstract available.

PMID:
17222090
22.

Tumour of great occipital foramen.

Mitosek-Szewczyk K, Stelmasiak Z.

Ann Univ Mariae Curie Sklodowska Med. 2004;59(2):410-2.

PMID:
16146119
23.

Oligoclonal bands measured in unconcentrated cerebrospinal fluid and other biochemical parameters in multiple sclerosis.

Kurzepa J, Nastaj M, Mitosek-Szewczyk K, Bartosik-Psujek H, Stelmasiak Z.

Ann Univ Mariae Curie Sklodowska Med. 2004;59(2):392-6.

PMID:
16146115
24.

Escalating immunotherapy of multiple sclerosis--new aspects and practical application.

Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, Buettner U, Chofflon M, Götschi-Fuchs M, Hess K, Kappos L, Kesselring J, Goebels N, Ludin HP, Mattle H, Schluep M, Vaney C, Baumhackl U, Berger T, Deisenhammer F, Fazekas F, Freimüller M, Kollegger H, Kristoferitsch W, Lassmann H, Markut H, Strasser-Fuchs S, Vass K, Altenkirch H, Bamborschke S, Baum K, Benecke R, Brück W, Dommasch D, Elias WG, Gass A, Gehlen W, Haas J, Haferkamp G, Hanefeld F, Hartung HP, Heesen C, Heidenreich F, Heitmann R, Hemmer B, Hense T, Hohlfeld R, Janzen RW, Japp G, Jung S, Jügelt E, Koehler J, Kölmel W, König N, Lowitzsch K, Manegold U, Melms A, Mertin J, Oschmann P, Petereit HF, Pette M, Pöhlau D, Pohl D, Poser S, Sailer M, Schmidt S, Schock G, Schulz M, Schwarz S, Seidel D, Sommer N, Stangel M, Stark E, Steinbrecher A, Tumani H, Voltz R, Weber F, Weinrich W, Weissert R, Wiendl H, Wiethölter H, Wildemann U, Zettl UK, Zipp F, Zschenderlein R, Izquierdo G, Kirjazovas A, Packauskas L, Miller D, Koncan Vracko B, Millers A, Orologas A, Panellus M, Sindic CJ, Bratic M, Svraka A, Vella NR, Stelmasiak Z, Selmaj K, Bartosik-Psujik H, Mitosek-Szewczyk K, Belniak E, Mochecka A, Bayas A, Chan A, Flachenecker P, Gold R, Kallmann B, Leussink V, Mäurer M, Ruprecht K, Stoll G, Weilbach FX; Multiple Sclerosis Therapy Consensus Group.

J Neurol. 2004 Nov;251(11):1329-39. Review.

PMID:
15592728
25.

[Development of binding antibodies to interferon-beta during treatment of multiple sclerosis with different types of interferon-beta].

Bartosik-Psujek H, Mitosek-Szewczyk K, Belniak E, Stelmasiak Z.

Pol Merkur Lekarski. 2004 Jul;17(97):28-32. Polish.

PMID:
15559606
26.

Interleukin-8 and RANTES levels in patients with relapsing-remitting multiple sclerosis (RR-MS) treated with cladribine.

Bartosik-Psujek H, Belniak E, Mitosek-Szewczyk K, Dobosz B, Stelmasiak Z.

Acta Neurol Scand. 2004 Jun;109(6):390-2.

PMID:
15147461
27.

[The assessment of development of binding antibodies to interferon beta during interferon beta 1a treatment of multiple sclerosis].

Bartosik-Psujek H, Belniak E, Mitosek-Szewczyk K, Rejdak K, Dobosz B, Stelmasiak Z.

Neurol Neurochir Pol. 2003;37(4):799-809. Polish.

PMID:
14746240
28.

The use of instrumental examinations in the diagnosis of headaches.

Tynecka-Turowska M, Krasińska-Czerlunczakiewicz H, Mitosek-Szewczyk K, Stelmasiak Z.

Neurol Sci. 2003 Nov;24(4):305-7.

PMID:
14658058
29.

Problems in diagnosing cranial base meningioma in patients with multiple sclerosis.

Mitosek-Szewczyk K, Stelmasiak Z.

Neurol Sci. 2003 Nov;24(4):296-8.

PMID:
14658055
30.
31.

[Neurologic problems in tick-borne diseases--clinical and diagnostic aspects].

Bartosik-Psujek H, Belniak E, Mitosek-Szewczyk K, Stelmasiak Z.

Przegl Epidemiol. 2002;56 Suppl 1:30-7. Review. Polish.

PMID:
12194227
32.

[Tick-borne encephalitis versus multiple sclerosis: clinical and immunological aspects].

Bartosik-Psujek H, Mitosek-Szewczyk K, Belniak E, Stelmasiak Z, Kamiński M.

Neurol Neurochir Pol. 2001;35(4 Suppl):87-95. Review. Polish.

PMID:
11873620
33.

The levels of C3 and C4 components of the complement in the sera of relapsing-remitting multiple sclerosis patients (RR-MS) treated by 2-CDA (cladribine).

Bartosik-Psujek H, Stelmasiak Z, Mitosek-Szewczyk K, Belniak-Legieć E, Dobosz B.

Ann Univ Mariae Curie Sklodowska Med. 2000;55:231-4. No abstract available.

PMID:
11482079
34.

First neurological symptoms of multiple sclerosis.

Belniak-Legieć E, Bartosik-Psujek H, Mitosek-Szewczyk K, Buraczyńska K, Nowicki J, Stelmasiak Z.

Ann Univ Mariae Curie Sklodowska Med. 2000;55:227-30. No abstract available.

PMID:
11482078
35.

The effect of cladribine on some parameters of blood and cerebrospinal fluid in patients with relapsing-remitting multiple sclerosis (RR-MS).

Stelmasiak Z, Bartosik-Psujek H, Belniak-Legieć E, Mitosek-Szewczyk K.

Ann Univ Mariae Curie Sklodowska Med. 2000;55:221-5. No abstract available.

PMID:
11482077
36.

Interleukin-6 concentration in serum and cerebrospinal fluid in multiple sclerosis patients.

Stelmasiak Z, Kozioł-Montewka M, Dobosz B, Rejdak K, Bartosik-Psujek H, Mitosek-Szewczyk K, Belniak-Legieć E.

Med Sci Monit. 2000 Nov-Dec;6(6):1104-8.

PMID:
11208463
37.

Idiopathic hypoparathyroidism with intracranial calcifications and dominant skin manifestations.

Stelmasiak Z, Tarach JS, Nowicka-Tarach BM, Mitosek-Szewczyk K, Drop A.

Med Sci Monit. 2000 Jan-Feb;6(1):145-50.

38.

APOE genotype is a major predictor of long-term progression of disability in MS.

Chapman J, Vinokurov S, Achiron A, Karussis DM, Mitosek-Szewczyk K, Birnbaum M, Michaelson DM, Korczyn AD.

Neurology. 2001 Feb 13;56(3):312-6.

PMID:
11171894
39.

[Intervertebral discitis caused by staphylococcal sepsis].

Mitosek-Szewczyk K, Stelmasiak Z, Bekasińska-Figatowska M, Drop A, Walecki J.

Neurol Neurochir Pol. 2000 Jul-Aug;34(4):767-74. Polish.

PMID:
11105308
40.

[Differential diagnosis in multiple sclerosis: description of selected cases].

Stelmasiak Z, Bartosik-Psujek H, Belniak-Legieć E, Gustyn T, Mitosek-Szewczyk K, Semczuk W, Krasińska-Czerlunczakiewicz H.

Neurol Neurochir Pol. 2000;34(3 Suppl):45-53. Polish.

PMID:
10983300
41.

[Arteriovenous angioma of the cerebellum associated with trigeminal neuralgia].

Mitosek-Szewczyk K, Chyrchel U, Obel J.

Neurol Neurochir Pol. 1997 Sep-Oct;31(5):1019-25. Polish. No abstract available.

PMID:
9513964
42.

[Dialysis therapy and central nervous system disturbances].

Bartosik-Psujek H, Mitosek-Szewczyk K, Wojczal J.

Neurol Neurochir Pol. 1997 Sep-Oct;31(5):971-6. Review. Polish.

PMID:
9513959
43.

Uraemic autonomic neuropathy.

Bartosik-Psujek H, Psujek M, Mitosek-Szewczyk K.

Ann Univ Mariae Curie Sklodowska Med. 1996;51:133-8. Review.

PMID:
9467260
44.

Cerebral strokes immunopathology.

Iłzecka J, Mitosek-Szewczyk K.

Ann Univ Mariae Curie Sklodowska Med. 1996;51:103-7. Review.

PMID:
9467255
46.

The case of clinically benign spino-cerebral meningitis in the development of cranial basis neoplasm.

Mitosek-Szewczyk K, Iłzecka J.

Ann Univ Mariae Curie Sklodowska Med. 1994;49:105-8. No abstract available.

PMID:
8771837
47.

[Analysis of the pathogenesis of various post-traumatic strokes].

Pilarczyk M, Mitosek-Szewczyk K.

Wiad Lek. 1989 Dec 1;41(23):1621-4. Polish. No abstract available.

PMID:
2763564

Supplemental Content

Loading ...
Support Center